Sutro Biopharma STRO Payments To Acquire Equipment And Leasehold Improvements
Payments To Acquire Equipment And Leasehold Improvements at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept stro:PaymentsToAcquireEquipmentAndLeaseholdImprovements.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's payments to acquire equipment and leasehold improvements.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's payments to acquire equipment and leasehold improvements?
- Sutro Biopharma (STRO) reported payments to acquire equipment and leasehold improvements of $11K in Q1 2026.
- How has Sutro Biopharma's payments to acquire equipment and leasehold improvements changed year-over-year?
- Sutro Biopharma's payments to acquire equipment and leasehold improvements decreased by 99.1% year-over-year, from $1.17M to $11K.
- What is the long-term trend for Sutro Biopharma's payments to acquire equipment and leasehold improvements?
- Over 4 years (2021 to 2025), Sutro Biopharma's payments to acquire equipment and leasehold improvements has grown at a -42.3% compound annual growth rate (CAGR), from $15.32M to $1.7M.
- What does payments to acquire equipment and leasehold improvements mean?
- This represents the cash outflows for capital expenditures related to the acquisition of tangible assets, machinery, and improvements to leased properties. It serves as a primary indicator of the company's investment in its physical infrastructure and long-term operational capacity. High levels of these payments typically signal ongoing expansion or maintenance of manufacturing and research facilities.